Aurigene Oncology

Founded in 2002, we are a clinical stage biotech company committed to bringing novel and effective therapeutics for the treatment of cancer. We leverage our deep expertise in oncology focused drug discovery and development to bring novel therapeutics to cancer patients. Since inception, we have discovered 19 novel chemical entities for clinical development. We have out-licensed several of these to pharmaceutical and biotech companies, while advancing a few on our own. We have built comprehensive drug discovery and development capabilities, nurtured a growing team of passionate scientists, and collaborated with partners across the world.